BBIO

Congressional Activity
BridgeBio Pharma, Inc. - Common Stock (BBIO) [ST]
ARIA INTELLIGENCE BRIEF

Disclosure filings for this Health Care sector security show a single member of Congress, Gil Cisneros, accounting for all seven disclosed trades — each of which is a purchase, with no sales recorded in the public record. Activity in the name spans from August 2025 through May 2026, placing the most recent disclosed transaction within the past year. No bipartisan co-trading clusters are present, as only one member has disclosed activity, and no executive-branch officials have filed transactions in this security within the public disclosure record.

Signal Congress surfaces public disclosure data. This is not investment advice and does not imply wrongdoing.
TOTAL TRADES
7
BUYS
7
SELLS
0
MEMBERS
1
unique traders
BIPARTISAN CLUSTERS
0
AVG ALPHA 60D
+6.67%
vs SPY benchmark
BBIO timeline5 trades · Congress · single source
Positioned by disclosure date. Click any marker for its source filing.
CongressCabinetContract cut8-K13D▲ buy  ▼ sell  ◆ n/a  ■ event
CONGRESSCABINETNov 25Jan 26Mar 26May 26
EXECUTIVE HOLDINGS
Primary-source OGE 278-T disclosures
View all on Executive page →
No OGE 278-T disclosures found for BBIO.
7 trades
Congressional trading data from STOCK Act filings. Not investment advice.
MEMBERS WHO TRADED BBIO · 1
Gil Cisneros7